Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2020 Filed May 7, 2020 21:08 UTC |
Duncan Candace HDirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000059 · wf-form4_158888568902252.xml · nonDerivative · entry 1 Duncan Candace H · CIK 0001606555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,786.713 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:22 UTC |
Klasko Stephen K. M.D.Director
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000072 · wf-form4_158888655169606.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:22 UTC |
Klasko Stephen K. M.D.Director
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000072 · wf-form4_158888655169606.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120.941 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:20 UTC |
HAGGERTY GRETCHEN RDirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000070 · wf-form4_158888644102315.xml · derivative · entry 2 HAGGERTY GRETCHEN R · CIK 0001236161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:20 UTC |
HAGGERTY GRETCHEN RDirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000070 · wf-form4_158888644102315.xml · nonDerivative · entry 1 HAGGERTY GRETCHEN R · CIK 0001236161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:19 UTC |
HEINMILLER JOHN CDirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000068 · wf-form4_158888632496572.xml · derivative · entry 2 HEINMILLER JOHN C · CIK 0001233296 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:19 UTC |
HEINMILLER JOHN CDirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000068 · wf-form4_158888632496572.xml · nonDerivative · entry 1 HEINMILLER JOHN C · CIK 0001233296 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,114 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:17 UTC |
Deren JohnVP & Chief Accounting Officer
|
SaleCommon Stock | 267 | $329.67 | $88,021.57 |
DisclosureSEC source: 0000096943-20-000066 · wf-form4_158888622075979.xml · nonDerivative · entry 2 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 986 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:17 UTC |
Deren JohnVP & Chief Accounting Officer
|
SaleCommon Stock | 826 | $330.24 | $272,775.35 |
DisclosureSEC source: 0000096943-20-000066 · wf-form4_158888622075979.xml · nonDerivative · entry 1 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 F1 · price: This transaction was executed in multiple trades at prices ranging from $329.911300 to $330.76. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:15 UTC |
BABICH GEORGE JRDirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000064 · wf-form4_158888611823406.xml · derivative · entry 3 BABICH GEORGE JR · CIK 0001179563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:15 UTC |
BABICH GEORGE JRDirector
|
GrantCommon Stock | 514 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000064 · wf-form4_158888611823406.xml · nonDerivative · entry 1 BABICH GEORGE JR · CIK 0001179563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,031.002 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:12 UTC |
PACKER RICHARD ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000062 · wf-form4_158888592770076.xml · derivative · entry 2 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:12 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000062 · wf-form4_158888592770076.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,712.808 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:05 UTC |
Krakauer Andrew ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000057 · wf-form4_158888549293056.xml · derivative · entry 2 Krakauer Andrew A · CIK 0001302168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:05 UTC |
Krakauer Andrew ADirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000057 · wf-form4_158888549293056.xml · nonDerivative · entry 1 Krakauer Andrew A · CIK 0001302168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232.324 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:00 UTC |
RANDLE STUART ADirector
|
GrantStock Option / (Right to Buy) · Derivative | 1,187 | $0.00 Strike: $340.75 | $0.00 |
DisclosureSEC source: 0000096943-20-000055 · wf-form4_158888521468690.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Stock · 1,187 shares Expires 2030-05-05 Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:00 UTC |
RANDLE STUART ADirector
|
GrantCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000055 · wf-form4_158888521468690.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,898 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 5, 2020. Read SEC document |
| May 05, 2020 Filed Feb 9, 2021 00:44 UTC |
Leyden James JVP, General Counsel, Secretary
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-21-000005 · wf-form5_161283142187112.xml · nonDerivative · entry 1 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,974 Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · derivative · entry 4 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $342.26 | $68,452.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 21:07 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000048 · wf-form4_158810805090993.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| March 25, 2020 Filed Mar 26, 2020 16:54 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000045 · wf-form4_158524163816199.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| March 25, 2020 Filed Mar 26, 2020 16:54 UTC |
Klasko Stephen K. M.D.Director
|
SaleCommon Stock | 200 | $254.75 | $50,950.00 |
DisclosureSEC source: 0000096943-20-000045 · wf-form4_158524163816199.xml · nonDerivative · entry 2 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737.941 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| March 25, 2020 Filed Mar 26, 2020 16:54 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionCommon Stock | 200 | $58.25 | $11,650.00 |
DisclosureSEC source: 0000096943-20-000045 · wf-form4_158524163816199.xml · nonDerivative · entry 1 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937.941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 969 | $0.00 Strike: $253.72 | $0.00 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · derivative · entry 7 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970 Underlying: Common Stock · 969 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/27/2019, 2/27/2020 and 2/27/2021. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 1,215 | $0.00 Strike: $191.18 | $0.00 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · derivative · entry 6 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,215 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/28/2018, 2/28/2019 and 2/28/2020. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
SaleCommon Stock | 2,184 | $346.17 | $756,035.28 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · nonDerivative · entry 4 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,079 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 969 | $253.72 | $245,854.68 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · nonDerivative · entry 3 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,215 | $191.18 | $232,283.70 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · nonDerivative · entry 2 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:15 UTC |
Deren JohnVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 154 | $335.02 | $51,593.08 |
DisclosureSEC source: 0000096943-20-000043 · wf-form4_158327012832995.xml · nonDerivative · entry 1 Deren John · CIK 0001706189 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,079 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:14 UTC |
Hicks Cameron PVice President, Global HR
|
Tax withholdingCommon Stock | 266 | $335.02 | $89,115.32 |
DisclosureSEC source: 0000096943-20-000041 · wf-form4_158327004307223.xml · nonDerivative · entry 1 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250.02 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:12 UTC |
Leyden James JVP, General Counsel, Secretary
|
Tax withholdingCommon Stock | 380 | $335.02 | $127,307.60 |
DisclosureSEC source: 0000096943-20-000039 · wf-form4_158326995070083.xml · nonDerivative · entry 1 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,506 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:10 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,035 | $335.02 | $346,745.70 |
DisclosureSEC source: 0000096943-20-000037 · wf-form4_158326979465102.xml · nonDerivative · entry 1 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,993 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:08 UTC |
Kelly LiamDirector · President & CEO
|
Tax withholdingCommon Stock | 1,031 | $335.02 | $345,405.62 |
DisclosureSEC source: 0000096943-20-000035 · wf-form4_158326968184761.xml · nonDerivative · entry 1 Kelly Liam · CIK 0001552476 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355.101 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock award. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 3,200 | $0.00 Strike: $61.34 | $0.00 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · derivative · entry 8 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Exercisable for one-third of the shares on each of 3/1/2011, 3/1/2012 and 3/1/2013. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
SaleCommon Stock | 350 | $344.29 | $120,503.01 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · nonDerivative · entry 5 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,886 Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
SaleCommon Stock | 400 | $344.26 | $137,704.00 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · nonDerivative · entry 4 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,236 Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
Tax withholdingCommon Stock | 705 | $344.44 | $242,830.20 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · nonDerivative · entry 3 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,636 Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:49 UTC |
Leyden James JVP, General Counsel, Secretary
|
Exercise / conversionCommon Stock | 3,200 | $61.34 | $196,288.00 |
DisclosureSEC source: 0000096943-20-000031 · wf-form4_158285097575476.xml · nonDerivative · entry 2 Leyden James J · CIK 0001289464 · VP, General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:52 UTC |
Wijker MarioVice President, QARA
|
GrantStock Option / (Right to Buy) · Derivative | 1,940 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000027 · wf-form4_158275390804466.xml · derivative · entry 2 Wijker Mario · CIK 0001803970 · Vice President, QARA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 1,940 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:52 UTC |
Wijker MarioVice President, QARA
|
GrantCommon Stock | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000027 · wf-form4_158275390804466.xml · nonDerivative · entry 1 Wijker Mario · CIK 0001803970 · Vice President, QARA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582 F1 · kind: Restricted Stock Unit award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:54 UTC |
Hicks Cameron PVice President, Global HR
|
GrantStock Option / (Right to Buy) · Derivative | 3,997 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000029 · wf-form4_158275402739903.xml · derivative · entry 3 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,997 Underlying: Common Stock · 3,997 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:54 UTC |
Hicks Cameron PVice President, Global HR
|
GrantCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000029 · wf-form4_158275402739903.xml · nonDerivative · entry 1 Hicks Cameron P · CIK 0001627036 · Vice President, Global HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,516.02 F1 · kind: Restricted Stock Unit award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:50 UTC |
Kelly LiamDirector · President & CEO
|
GrantStock Option / (Right to Buy) · Derivative | 31,371 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000025 · wf-form4_158275377314498.xml · derivative · entry 2 Kelly Liam · CIK 0001552476 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,371 Underlying: Common Stock · 31,371 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:50 UTC |
Kelly LiamDirector · President & CEO
|
GrantCommon Stock | 3,215 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000025 · wf-form4_158275377314498.xml · nonDerivative · entry 1 Kelly Liam · CIK 0001552476 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,386.101 F1 · kind: Restricted Stock Unit award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:46 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
GrantStock Option / (Right to Buy) · Derivative | 12,992 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000021 · wf-form4_158275358697319.xml · derivative · entry 3 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,992 Underlying: Common Stock · 12,992 shares Expires 2030-02-25 F2 · derivative.exercise_date: Excercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:46 UTC |
POWELL THOMAS EExecutive Vice President & CFO
|
GrantCommon Stock | 1,331 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000021 · wf-form4_158275358697319.xml · nonDerivative · entry 1 POWELL THOMAS E · CIK 0001242740 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,028 F1 · kind: Restricted Stock Unit award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:48 UTC |
Winters JamesVice President, Mfg and Supply
|
GrantStock Option / (Right to Buy) · Derivative | 3,234 | $0.00 Strike: $348.11 | $0.00 |
DisclosureSEC source: 0000096943-20-000023 · wf-form4_158275368753424.xml · derivative · entry 2 Winters James · CIK 0001804149 · Vice President, Mfg and Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,234 Underlying: Common Stock · 3,234 shares Expires 2030-02-25 F2 · derivative.exercise_date: Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:48 UTC |
Winters JamesVice President, Mfg and Supply
|
GrantCommon Stock | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0000096943-20-000023 · wf-form4_158275368753424.xml · nonDerivative · entry 1 Winters James · CIK 0001804149 · Vice President, Mfg and Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 963 F1 · kind: Restricted Stock Award granted pursuant to the Teleflex Incorporated 2014 Stock Incentive Plan. Shares vest 100% on the third anniversary of the grant date. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 18:36 UTC |
Klasko Stephen K. M.D.Director
|
Exercise / conversionStock Option / (Right to Buy) · Derivative | 200 | $0.00 Strike: $58.25 | $0.00 |
DisclosureSEC source: 0000096943-20-000019 · wf-form4_158274217553577.xml · derivative · entry 3 Klasko Stephen K. M.D. · CIK 0001433241 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 200 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 26, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.